APH - Company ID 0000820313
The table below shows AMPHENOL CORP /DE/'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $10.23B | $8.76B | $7.62B | $6.19B | $5.65B | $4.81B |
| Cost of revenue | $6.21B | $5.21B | $4.82B | $3.84B | $3.60B | $3.17B |
| Gross profit | $4.02B | $3.55B | $2.80B | $2.36B | $2.05B | $1.64B |
| R&D | - | - | - | - | - | - |
AMPHENOL CORP /DE/ reported annual revenue of $23.09B for fiscal year 2025. That is up 51.7% from $15.22B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $6.29B (FY 2016) to $23.09B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $979.90M |
| $939.90M |
| $851.50M |
| $657.00M |
| $622.50M |
| $575.20M |
| Operating income | $3.02B | $2.58B | $1.83B | $1.70B | $1.42B | $1.02B |
| Income tax | $774.50M | $604.30M | $702.40M | $385.80M | $247.30M | $218.70M |
| Net income | $2.03B | $1.77B | $933.00M | $1.25B | $1.09B | $737.80M |
| EPS (diluted) | $0.79 | $1.37 | $0.72 | $0.97 | $0.86 | $0.58 |